Peer-influenced content. Sources you trust. No registration required. This is HCN.
ACP Internist
Stay updated with the latest advancements in the management of hypoparathyroidism. Enhance your knowledge and improve patient outcomes by understanding the nuances of diagnosis and treatment.
Endocrinology, Diabetes, Metabolism November 15th 2023
Medical Professionals Reference (MPR)
The oral solution revealed 95% of the labeled amount of levothyroxine sodium (T4) for the affected lots. This recall does not apply to Tirosint capsules.
Endocrinology, Diabetes, Metabolism March 2nd 2023